ErbB receptors: new insights on mechanisms and biology
- PMID: 17085050
- DOI: 10.1016/j.tcb.2006.10.008
ErbB receptors: new insights on mechanisms and biology
Abstract
The ErbB family of four receptor tyrosine kinases occupies a central role in a wide variety of biological processes from neuronal development to breast cancer. New information continues to expand their biologic significance and to unravel the molecular mechanisms that underlie the signaling capacity of these receptors. Here, we review several aspects of ErbB receptor physiology for which new and significant information is available. These include ligand-dependent receptor dimerization and kinase activation, which is a prerequisite for all subsequent growth factor-dependent cell responses. We also address novel roles of receptor fragments in signaling, trafficking to intracellular sites, such as the nucleus, and ErbB roles in non-cancer disease processes, including schizophrenia, chronic renal disease, hypertension, and the cellular entry of infectious pathogens.
Similar articles
-
Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction.Nat Biotechnol. 2004 Feb;22(2):198-203. doi: 10.1038/nbt929. Epub 2004 Jan 4. Nat Biotechnol. 2004. PMID: 14704683
-
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.Mol Cell. 2003 Sep;12(3):541-52. doi: 10.1016/s1097-2765(03)00350-2. Mol Cell. 2003. PMID: 14527402 Review.
-
Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.Exp Cell Res. 2002 Apr 15;275(1):9-16. doi: 10.1006/excr.2002.5494. Exp Cell Res. 2002. PMID: 11925101
-
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.EMBO J. 1998 Jun 15;17(12):3385-97. doi: 10.1093/emboj/17.12.3385. EMBO J. 1998. PMID: 9628875 Free PMC article.
-
EGF-ERBB signalling: towards the systems level.Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16. doi: 10.1038/nrm1962. Nat Rev Mol Cell Biol. 2006. PMID: 16829981 Review.
Cited by
-
The ErbB Signaling Network and Its Potential Role in Endometrial Cancer.Epigenomes. 2023 Oct 1;7(4):24. doi: 10.3390/epigenomes7040024. Epigenomes. 2023. PMID: 37873809 Free PMC article. Review.
-
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.Mol Ther Oncolytics. 2023 Sep 16;31:100728. doi: 10.1016/j.omto.2023.100728. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 37822488 Free PMC article.
-
CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer.Cell Death Dis. 2023 Feb 3;14(2):81. doi: 10.1038/s41419-023-05608-3. Cell Death Dis. 2023. PMID: 36737605 Free PMC article.
-
HER3 in cancer: from the bench to the bedside.J Exp Clin Cancer Res. 2022 Oct 21;41(1):310. doi: 10.1186/s13046-022-02515-x. J Exp Clin Cancer Res. 2022. PMID: 36271429 Free PMC article. Review.
-
The role of HER2 alterations in clinicopathological and molecular characteristics of breast cancer and HER2-targeted therapies: a comprehensive review.Med Oncol. 2022 Sep 29;39(12):210. doi: 10.1007/s12032-022-01817-6. Med Oncol. 2022. PMID: 36175719 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
